Use our four steps to introduce technology-based supply chain risk management within your enterprise in the pharmaceutical and biotechnology industry.

Specialty and small volume suppliers and highly technical shipping requirements put pharmaceutical and biotechnology supply chains at risk of disruption. Shortages and quality issues could severely damage a company’s reputation.

To manage these and other risks, supply chain risk management (SCRM) must be deeply rooted in procurement and supplier management. The goal is to create a powerful SCRM program fueled by solid structures, educated teams and digital technology. But how do you get started?

This framework guides you through four steps:
  • Understand the status quo to determine your risk maturity.
  • Develop your supply chain risk management strategy.
  • Implement your best-in-class approach.
  • Create and deliver long-term value.

Learn how to successfully introduce an SCRM program within your enterprise in the pharmaceutical and biotechnology industry. Get started now on your journey to greater supply chain resilience!

Fill out the form to receive your white paper.

Circles-1 (1)
WP 019 – Managing Risk in the Pharmaceutical and Biotechnology Supply Chain copy

Latest insights from Sphera

UK Sustainability Reporting Standards (UK SRS): What Investors Expect and Companies Should Do Next

UK Sustainability Reporting Standards (UK SRS): What Investors Expect and Companies Should Do Next

The UK SRS are here. Align your reporting with ISSB standards and the new S1 and S2 frameworks…
April 7, 2026
The ESRS Reset: What Really Changed and What Didn’t

The ESRS Reset: What Really Changed and What Didn’t

ESRS updates cut data points by 60%, shifting the focus to professional judgment and materiality. See how to…
April 6, 2026
Why companies need to start implementing climate transition plans now​

Why companies need to start implementing climate transition plans now​

Move from climate ambition to business transformation. Learn why IFRS S2, CSRD, and TPT make quantified transition planning…
April 2, 2026